1. Home
  2. ACCL vs PDSB Comparison

ACCL vs PDSB Comparison

Compare ACCL & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.58

Market Cap

36.3M

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.22

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCL
PDSB
Founded
2009
2005
Country
Hong Kong
United States
Employees
N/A
10
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
42.4M
IPO Year
2024
2015

Fundamental Metrics

Financial Performance
Metric
ACCL
PDSB
Price
$2.58
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $4.75
AVG Volume (30 Days)
54.6K
★ 50.3M
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.16
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$0.20
52 Week High
$5.00
$1.55

Technical Indicators

Market Signals
Indicator
ACCL
PDSB
Relative Strength Index (RSI) 44.51 78.42
Support Level $2.42 $0.58
Resistance Level $3.16 $1.32
Average True Range (ATR) 0.16 0.15
MACD -0.03 0.03
Stochastic Oscillator 20.31 86.66

Price Performance

Historical Comparison
ACCL
PDSB

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: